MLchartDataset catalogue

autologous natural killer cells SNK01

Term · Oncology and biomedicine · MLC-T-ONC-011713

A preparation of autologous, ex-vivo expanded and activated natural killer (NK) cells, with potential cytolytic and antineoplastic activities. Upon infusion back into the patient, the autologous NK cells SNK01 may lyse cancer cells. These cells also secrete pro-inflammatory cytokines, which further stimulate an anti-tumor immune response.

Table 1. Record
IdentifierMLC-T-ONC-011713
FieldOncology and biomedicine
Synonymsautologous NKCs SNK01; autologous NK cells SNK01
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011713",
  "term": "autologous natural killer cells SNK01",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous, ex-vivo expanded and activated natural killer (NK) cells, with potential cytolytic and antineoplastic activities. Upon infusion back into the patient, the autologous NK cells SNK01 may lyse cancer cells. These cells also secrete pro-inflammatory cytokines, which further stimulate an anti-tumor immune response.",
  "synonyms": [
    "autologous NKCs SNK01",
    "autologous NK cells SNK01"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-natural-killer-cells-snk01/"
}

Record 3,049 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.